Bradford Health Acquires Parkdale Center, Expanding Specialized Addiction Care

BIRMINGHAM, Ala. – February 23, 2026 – Bradford Health Services, a major provider of substance use disorder treatment across the Southeast, has announced its expansion into the Midwest through the acquisition of Parkdale Center, an Indiana-based facility renowned for its confidential addiction treatment programs for licensed professionals. The move signals a significant strategic push to serve a high-stakes demographic and establishes a key foothold for Bradford in a new geographic market.

Parkdale Center, located in Chesterton, Indiana, has built a distinguished reputation for serving healthcare providers, attorneys, executives, pilots, and first responders. The acquisition allows Bradford to integrate this highly specialized model into its broader network.

“Parkdale Center has built an outstanding reputation for delivering highly specialized, confidential care to professionals whose careers and licensure depend on successful recovery,” said Rob Marsh, CEO of Bradford Health Services. “Their evidence-based treatment protocols, impressive outcomes, strong relationships with professional monitoring programs, and commitment to sustainable long-term recovery align closely with Bradford’s mission. We are proud to welcome Parkdale into the Bradford family.”

Claudia Garcia, CEO and Founder of Parkdale Center, echoed the sentiment of a shared mission. “Joining the Bradford treatment network allows us to expand our impact while preserving the unique and differentiated care model that defines Parkdale,” she stated. “We share a deep commitment to clinical excellence, family engagement, and long-term recovery outcomes.”

A Strategic Move into a Growing Market

The acquisition is the latest in a series of calculated moves by Bradford Health Services to consolidate its position as a national leader in addiction treatment. Backed by private equity firm Lee Equity Partners since October 2022, Bradford has pursued an aggressive growth strategy focused on acquiring best-in-class operators and expanding its service lines. This pattern includes the 2021 acquisition of Tennessee’s Cornerstone of Recovery and more recent expansions into Florida and Texas, demonstrating a clear objective to build a comprehensive, multi-state network.

This latest transaction marks Bradford’s strategic entry into the Midwest, a region with a growing need for behavioral health services. The market for substance use disorder treatment centers in Indiana, for example, has been expanding at an average annual rate of 6.0% in recent years. Furthermore, Indiana’s regulatory landscape, which does not require a Certificate of Need (CON) for behavioral health facilities, creates a favorable environment for expanding access to care.

By acquiring an established and respected entity like Parkdale, Bradford bypasses the challenges of building a brand from scratch in a new territory. Instead, it immediately gains a CARF-accredited facility with a proven track record and deep community ties, positioning itself as a key player in the region’s specialized treatment ecosystem.

Addressing the Silent Crisis Among Professionals

The true significance of the merger lies in its focus on professionals, a group that faces unique and formidable barriers to seeking help for addiction. For doctors, lawyers, pilots, and first responders, the stigma of a substance use disorder is compounded by the immense fear of losing their license, destroying their reputation, and ending a career built over decades. Confidentiality is not just a preference; it is a necessity.

Parkdale Center built its entire model around this reality. The center is known for its discretion and its programs tailored to the high-functioning, high-stress lives of its clients. This includes allowing limited, structured access to laptops and phones so professionals can manage critical work responsibilities while in treatment.

Crucially, Parkdale’s services extend beyond clinical therapy. Its “Career Restoration Program” is a cornerstone of its model, providing clients with vital support in navigating the complex web of licensing boards, legal issues, and professional monitoring programs. This active advocacy is essential for facilitating a successful and sustainable return to work. The center's deep experience working with these regulatory bodies helps to demystify the process for clients and promote a path to recovery that protects both their livelihood and public trust. This specialized focus has yielded impressive results, with Parkdale reporting sobriety rates significantly higher than national averages, including a one-year sobriety rate of 89.2% for alumni of its core programs.

A Shared Standard of Clinical Excellence

At the heart of the acquisition is what both organizations describe as a shared philosophy centered on clinical excellence and evidence-based care. Parkdale Center holds a "Three-Year Accreditation" from CARF International, the highest level awarded, signifying adherence to rigorous international standards for quality and outcomes.

This commitment is reflected in a comprehensive and integrated treatment approach. The center offers a full continuum of care, ensuring clients receive the appropriate level of support at every stage of their recovery. This includes medically supervised withdrawal management, Partial Hospitalization Programs (PHP), Intensive Outpatient Programs (IOP), sober living facilities, and long-term aftercare support.

Treatment is grounded in a range of proven therapeutic modalities, including Cognitive Behavioral Therapy (CBT), Dialectical Behavior Therapy (DBT), Acceptance and Commitment Therapy (ACT), and Eye Movement Desensitization and Reprocessing (EMDR). This multi-faceted approach allows clinicians to tailor care plans to individual needs, addressing not only the addiction but also co-occurring mental health conditions like trauma, anxiety, and depression, which are especially prevalent among first responders and other high-stress professions. The program also heavily emphasizes family involvement, featuring a two-day intensive family curriculum and ongoing virtual support to heal the entire family system.

Consolidation and the Future of Addiction Care

The Bradford-Parkdale deal is a microcosm of a larger trend reshaping the American healthcare landscape: the rapid consolidation of the behavioral health industry. Fueled by a surge in private equity investment and a growing recognition of unmet mental health and addiction needs, the market for treatment facilities is projected to nearly double from $16.8 billion in 2023 to over $31 billion by 2033.

In this environment, independent centers are increasingly joining larger platforms that can provide capital, operational infrastructure, and negotiating power with insurers. For Parkdale, joining the Bradford network provides the resources to scale its impact and reach more professionals in need. For Bradford, the acquisition is more than just a line on a map; it represents a deepening of its clinical capabilities in a lucrative and socially critical niche.

By integrating Parkdale’s specialized expertise, Bradford strengthens its national value proposition, offering a robust continuum of care that now includes a premier, destination program for professionals. This move enhances its ability to serve a nationwide clientele who require discreet, high-quality treatment tailored to the unique challenges of their careers, solidifying its role as a formidable national provider in the addiction treatment space.